MRTTSE:6034 -0.79%63 FCF Yield % is 9.10 as of Jul. 06, 2026, which is 487% above its 10-year median of 1.55. GuruFocus rates TSE:6034 with a GF Score™ of 63/100 and a GF Value™ of 円634.80 (Fairly Valued). The stock has 4 warning signs investors should review. Among 681 Healthcare Providers & Services companies, MRT ranks better than 80.47% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
As of today, MRT's Trailing 12-Month Free Cash Flow is 円311 Mil, and Market Cap is 円3,421 Mil. Therefore, MRT's FCF Yield % for today is 9.10%.
The historical rank and industry rank for MRT's FCF Yield % or its related term are showing as below:
TSE:6034'
s FCF Yield % Range Over the Past 10 Years
Min: -12.16 Med: 1.55 Max: 63.56
Current: 9.1
During the past 12 years, the highest FCF Yield % of MRT was 63.56%. The lowest was -12.16%. And the median was 1.55%.
TSE:6034's FCF Yield % is ranked better than 80.47% of 681
companies
in the Healthcare Providers & Services industry
Industry Median: 1.83
vs TSE:6034: 9.10
MRT's FCF Margin % for the quarter that ended in Mar. 2026 was -31.47%.
MRT FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
MRT FCF Yield % Related Terms
MRT FCF Yield % Historical Data
* Premium members only.
The historical data trend for MRT's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, MRT's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MRT FCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MRT's FCF Yield % distribution charts can be found below:
* The bar in red indicates where MRT's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MRT (TSE:6034) has a FCF Yield % of 9.10 as of Jul. 06, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on MRT and its competitors. This is 487% above median its historical median of 1.55. According to the industry distribution chart, MRT ranks #133 out of 681 companies in the Healthcare Providers & Services industry, placing it in the top 19.5%.
Is MRT's FCF Yield % too high?
MRT's current FCF Yield % of 9.10 is 487% above median its 10-year median of 1.55. The Healthcare Providers & Services industry median FCF Yield % is 1.83. MRT's value of 9.10 is 397.3% above this industry median. Based on the distribution chart, MRT ranks #133 out of 681 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, MRT has a GF Score™ of 63/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does MRT's FCF Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, MRT ranks #133 out of 681 companies for FCF Yield %. This places MRT in the top 20% of its industry — outperforming the majority of peers. The industry median FCF Yield % is 1.83. MRT's value of 9.10 is 397.3% above this benchmark. While the company's 10-year median is 1.55 vs. the industry median of 1.83, MRT has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Healthcare Providers & Services company?
The median FCF Yield % among Healthcare Providers & Services companies is 1.83, based on 681 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MRT's current FCF Yield % of 9.10 is 397.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on MRT and its competitors. For the Healthcare Providers & Services industry, the median FCF Yield % is 1.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MRT's current FCF Yield % is 9.10, which is 487% above median its own 10-year median of 1.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MRT stock overvalued right now?
Based on GuruFocus' analysis, MRT (TSE:6034) is currently considered Fairly Valued. The stock's GF Value™ is 円634.80, compared to a current price of 円625.00 — trading 1.5% below its estimated fair value. The current FCF Yield % is 9.10, which is 487% above median its 10-year median of 1.55 and 397.3% above the Healthcare Providers & Services industry median of 1.83. MRT's overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For MRT (TSE:6034), the current FCF Yield % is 9.10 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MRT (TSE:6034) Overvalued in 2026?
Based on GuruFocus' analysis, MRT stock appears to be undervalued.
The current stock price of 円625.00 is trading 1.5% below its estimated GF Value™ of 円634.80.
GuruFocus considers MRT to be Fairly Valued.
Key valuation signals for TSE:6034:
FCF Yield %: 9.10 (487% above median its 10-year median of 1.55)
GF Value™: 円634.80 vs. price of 円625.00 (1.5% below fair value)
Industry Position: 397.3% above the Healthcare Providers & Services median (#133 of 681)
No single metric tells the full story. See the TSE:6034 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MRT Inc engages in the business of medical personnel placement services through the Internet. It provides part-time and full-time physician referral services through the physician referral site, as well as part-time job referral, job change introduction services to nurses, pharmacists, clinical laboratory technicians, clinical engineers, and radiologists. Further, the company engages in the research and development of analytical and analytical methods for various biological samples, such as microorganisms, blood, proteins, and genes; and research and development, manufacture, and sale of medical and medical examination equipment, and analytical instruments.
63GF Score
Get the complete analysis for TSE:6034
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6034 has been successfully added to your 
